Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo

Veterinary Journal

Volumn 191, Issue 1, 2012, Pages 115-120

  Wang, X F ^a   Zhang, S L ^a   Zhu, L Y ^a   Xie, S Y ^a   Dong, Z ^a   Wang, Y ^a   Zhou, W Z ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antibacterial activity; Mastitis model; Solid lipid nanoparticles; Therapeutic efficacy; Tilmicosin

Indexed keywords

HYDROGENATED CASTOR OIL; SOLID LIPID NANOPARTICLE; TILMICOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; CHEMICAL PROCEDURES; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; HOT HOMOGENIZATION; IN VITRO STUDY; IN VIVO STUDY; MAMMARY GLAND; MASTITIS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUSTAINED DRUG RELEASE; ULTRASONICATION; ZETA POTENTIAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CASTOR OIL; CATTLE; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; LIPIDS; MASTITIS, BOVINE; MICE; MICE, INBRED STRAINS; NANOPARTICLES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STEM CELLS; TYLOSIN;

STAPHYLOCOCCUS AUREUS;

EID: 84855541737     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.11.019     Document Type: Article

References (24)

1. Brouillette E., Grondin G., Lefebvre C., Talbot B.G., Malouin F. Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus. Veterinary Microbiology 2004, 101:253-262.
2. Brouillette E., Grondin G., Talbot B.G., Malouin F. Inflammatory cell infiltration as an indicator of Staphylococcus aureus infection and therapeutic efficacy in experimental mouse mastitis. Veterinary Immunology and Immunopathology 2005, 104:163-169.
3. Clark C., Woodbury M., Dowling P., Ross S., Boison J.O. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum. Journal of Veterinary Pharmacology and Therapeutics 2004, 27:385-387.
4. Eberhart R.J. Management of dry cows to reduce mastitis. Journal of Dairy Science 1986, 69:1721-1732.
5. Eric B., Francois M. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes and Infection 2005, 7:560-568.
6. Esmaeili F., Hosseini-Nasr M., Rad-Malekshahi M., Samadi N., Atyabi F., Dinarvand R. Preparation and antibacterial activity evaluation of rifampicin-loaded poly-lactide-co-glycolide nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 2007, 3:161-167.
7. Gruet P., Maincent P., Berthelot X., Kaltsatos V. Bovine mastitis and intramammary drug delivery: review and perspectives. Advanced Drug Delivery Reviews 2001, 50:245-259.
8. Han C., Qi C.M., Zhao B.K., Cao J., Xie S.Y., Wang S.L., Zhou W.Z. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies. Journal of Veterinary Pharmacology and Therapeutics 2009, 32:116-123.
9. Jordan W.H., Byrd R.A., Cochrane R.L., Hanasono G.K., Hoyt J.A., Main B.W., Meyerhoff R.D., Sarazan R.D. A review of the toxicology of the antibiotic MICOTIL 300. Veterinary and Human Toxicology 1993, 35:151-158.
10. Li S.Y., Zhao B.K., Wang F.H., Wang M., Xie S.Y., Wang S.L., Han C., Zhu L.Y., Zhou W.Z. Yak interferon-alpha loaded solid lipid nanoparticles for controlled release. Research in Veterinary Science 2010, 88:148-153.
11. National Committee for Clinical Laboratory Standards, 2003. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, sixth ed: Approved Standard M7-A6. NCCLS, Wayne, PA, USA.
12. Neave F.K., Dodd F.H., Kingwill R.G. A method of controlling udder disease. Veterinary Record 1966, 78:521-523.
13. Nickerson S.C., Owens W.E., Fox L.K., Scheifinger C.C., Shryock T.R., Spike T.E. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off. Journal of Dairy Science 1999, 82:696-703.
14. Owens W.E., Nickerson S.C., Ray C.H. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus mastitis during lactation. Journal of Dairy Science 1999, 82:645-647.
15. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews 2003, 55:329-347.
16. Ramadan A. Pharmacokinetics of tilmicosin in serum and milk of goats. Research in Veterinary Science 1997, 62:48-50.
17. Ranjita M., Sarbari A., Fahima D., Sanjeeb K.S. Sustained antibacterial activity of doxycycline-loaded poly(d,l-lactide-co-glycolide) and poly(e-caprolactone) nanoparticles. Nanomedicine 2009, 4:519-530.
18. Scorneaux B., Shryock T.R. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science 1999, 82:1202-1212.
19. Sears P.M., McCarthy K.K. Management and treatment of staphylococcal mastitis. Veterinary Clinics of North America 2003, 19:171-185.
20. Song Y.H., Bai X.H., Li Y. Determination of tilmicosin by ultraviolet spectrophotometry. Journal of Shanxi Medical University 2005, 36:71-73.
21. Vasir K., Tambwekar K., Garg S. Bioadhesive microspheres as a controlled drug delivery system. International Journal of Pharmaceutics 2003, 255:13-32.
22. Xie S.Y., Wang S.L., Zhao B.K., Han C., Wang M., Zhou W.Z. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids and Surfaces B: Biointerfaces 2008, 67:199-204.
23. Xu Z.N., Wang J., Shen W.H., Cen P.L. Study on the extraction equilibrium of tilmicosin between the aqueous and butyl acetate phases. Chemical Engineering Communications 2006, 193:427-437.
24. Zhu Y.M., Miao J.F., Fan H.J., Zou S.X., Chen W.H. Protective effect of CpG-DNA against mastitis induced by Staphylococcus aureus infection in a rat model. International Immunopharmacology 2007, 4:435-443.